Skip to content
← Holders

Remedium Capital Partners, LLC

What Remedium Capital Partners, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 2104501 · Filed Nov 13, 2026

Positions
6
Reported value
$273.6M
Opened
2
Closed
2
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Dec 31, 2025$170.2K
    6 positions
  2. Mar 31, 2026$281.2M
    6 positions
  3. Jun 30, 2026$451.6M
    6 positions
  4. Sep 30, 2026$273.6M
    6 positions
SecuritySharesChangeValueOf portfolio
SYRESpyre Therapeutics, Inc.
1.2M−20.7%$103.3M37.8%
ORKAOruka Therapeutics, Inc.
954.2K−39.1%$79.5M29%
DMRADamora Therapeutics, Inc.
2MNew$43.5M15.9%
JBIOJade Biosciences, Inc.
1.8M+14.6%$25.4M9.3%
KRSAKorsana Biosciences, Inc.
518.5KNew$16.6M6.1%
CBIOCrescent Biopharma, Inc.
361.3K±0%$5.3M1.9%